Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries.
Inotiv stock last closed at $4.45, down 4.3% from the previous day, and has decreased 80.74% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.66 percentage points. Inotiv stock is currently +22.09% from its 52-week low of $3.65, and -83.65% from its 52-week high of $27.22.
As of Mar 20, 2023, there are 25.63M shares of NOTV outstanding. The market capitalization of NOTV is $114.06M. In the last 24 hours, 586,877 NOTV shares were traded.
You will need an online brokerage account to access the NASDAQ market and buy NOTV stock.
We believe that eToro is the best stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by signing up for an account with eToro now.Open eToro Account
Now that you've chosen the best brokerage, you need to fill out some personal details so you can buy NOTV stock today.
Now that you have finished signing up on the best stock app, you need to deposit funds:
Watch the video below if you need help transferring money into your brokerage account.
After you have decided on the best place to buy Inotiv stock, it's absolutely critical to evaluate their stock before you buy, so you can understand the risk and upside.
WallStreetZen was created to help everyday investors do more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on NOTV's stock page.
You can use many financial metrics, analyses, models, and charts to gauge NOTV's intrinsic value.
Using relative valuations measures:
You can access additional valuation analysis on NOTV's stock here.
Out of 2 Wall Street analysts who research NOTV, the consensus analyst rating on NOTV is a Buy
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
David Windley, a top 4% analyst from Jefferies downgrades NOTV to a hold rating and lowers their NOTV price target from $10.00 to $8.00, on Jan 19, 2023.
Frank Takkinen, a bottom 1% analyst from Lake Street upgrades NOTV to a strong buy rating and raises their NOTV price target from $4.00 to $10.00, on Jan 11, 2023.
You can dig deeper into what analysts are saying on the Inotiv stock forecast page.
Last year, NOTV revenue was $586.20M. During the last 5 year, NOTV's revenue has increased by 90.37% per year. This was faster than the Diagnostics & Research industry average of 16.31%.
You can research NOTV's earnings and revenue performance here.
Over the past year, insiders at NOTV have bought more shares than they have sold.
John E. Sagartz, Chief Strategy Officer of NOTV, was the latest NOTV insider to buy. They bought $25,041.00 worth of NOTV stock on Mar 14, 2023.
Dig into more about who owns NOTV stock here.
No, Inotiv doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
There are two primary options:
Press the Open button and your broker will execute your order.
If you require additional help investing in stocks on eToro, watch the how to video below:
Now that you own some shares in NOTV, you'll want to stay up-to-date on your new shares.
Put NOTV on a watchlist to monitor your NOTV stock.
To summarize, here are the 6 steps to buy stock in Inotiv:
If you need a brokerage, eToro is our recommended option.Get Started with eToro Today
If you would like to watch your new investment in Inotiv, create a watchlist today.
How much does it cost to buy one Inotiv share?
Is now a good time to buy Inotiv stock?
What is the best way to buy Inotiv stock?